GSK drug helps ovarian cancer patients live longer in late-stage study

40

GlaxoSmithKline Plc’s cancer treatment Zejula met the main goal of helping patients with ovarian cancer live longer without their disease worsening in a late-stage study, the company said on Monday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/tkIqhMTkxuo/gsk-drug-helps-ovarian-cancer-patients-live-longer-in-late-stage-study-idUSKCN1UA0IN